Therapeutic Area | MeSH |
---|---|
signs and symptoms pathological conditions | D013568 |
Brand Name | Status | Last Update |
---|---|---|
plasmanate | Biologic Licensing Application | 2010-04-30 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 1 | — | — | — | 1 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | 1 | — | — | — | 1 |
Alpha 1-antitrypsin deficiency | D019896 | — | E88.01 | — | 1 | — | — | — | 1 |
Fibrosis | D005355 | — | — | — | 1 | — | — | — | 1 |
Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | 1 | — | — | — | 1 |
Drug common name | Plasma protein fraction |
INN | — |
Description | Plasma protein fraction is an unknown pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Protein |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108773 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | — |